Amicus Therapeutics (FOLD)
Amicus Therapeutics Historical Price Data
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| May 25, 2012 | 4.89 | 5.03 | 4.804 | 4.99 | 70525 |
| May 24, 2012 | 4.78 | 4.90 | 4.72 | 4.90 | 111615 |
| May 23, 2012 | 4.51 | 4.89 | 4.37 | 4.76 | 171497 |
| May 22, 2012 | 4.81 | 4.87 | 4.50 | 4.55 | 63817 |
| May 21, 2012 | 4.69 | 4.94 | 4.64 | 4.80 | 90503 |
| May 18, 2012 | 4.89 | 4.89 | 4.50 | 4.67 | 703371 |
| May 17, 2012 | 5.36 | 5.36 | 4.87 | 4.88 | 81584 |
| May 16, 2012 | 5.36 | 5.46 | 5.240 | 5.37 | 52044 |
| May 15, 2012 | 5.04 | 5.45 | 4.98 | 5.30 | 81151 |
| May 14, 2012 | 4.71 | 5.09 | 4.68 | 5.02 | 93671 |
| May 11, 2012 | 4.69 | 5.00 | 4.66 | 4.72 | 59577 |
| May 10, 2012 | 4.88 | 4.94 | 4.65 | 4.72 | 88147 |
| May 9, 2012 | 4.96 | 5.03 | 4.75 | 4.85 | 97753 |
| May 8, 2012 | 5.35 | 5.44 | 4.92 | 5.04 | 494237 |
| May 7, 2012 | 4.96 | 5.025 | 4.920 | 4.98 | 55632 |
| May 4, 2012 | 5.07 | 5.07 | 4.95 | 4.97 | 69037 |
| May 3, 2012 | 5.26 | 5.26 | 5.04 | 5.12 | 51668 |
| May 2, 2012 | 5.06 | 5.38 | 5.06 | 5.29 | 94755 |
| May 1, 2012 | 4.91 | 5.195 | 4.87 | 5.12 | 138799 |
| April 30, 2012 | 5.28 | 5.28 | 4.85 | 4.88 | 148683 |
| April 27, 2012 | 5.23 | 5.28 | 5.120 | 5.27 | 43608 |
| April 26, 2012 | 5.04 | 5.30 | 4.980 | 5.19 | 90196 |
| April 25, 2012 | 4.88 | 5.08 | 4.85 | 5.04 | 125578 |
| April 24, 2012 | 4.66 | 4.85 | 4.65 | 4.80 | 82293 |
| April 23, 2012 | 4.60 | 4.68 | 4.41 | 4.67 | 153985 |
| April 20, 2012 | 4.63 | 4.81 | 4.53 | 4.72 | 48745 |
| April 19, 2012 | 4.68 | 4.79 | 4.54 | 4.56 | 74206 |
| April 18, 2012 | 4.75 | 4.80 | 4.64 | 4.66 | 61462 |
| April 17, 2012 | 4.79 | 5.10 | 4.75 | 4.76 | 183180 |
| April 16, 2012 | 5.01 | 5.01 | 4.68 | 4.73 | 101159 |
| April 13, 2012 | 4.82 | 5.00 | 4.75 | 4.99 | 106965 |
| April 12, 2012 | 4.97 | 4.97 | 4.77 | 4.86 | 87574 |
| April 11, 2012 | 4.88 | 5.10 | 4.87 | 4.95 | 217302 |
| April 10, 2012 | 4.85 | 4.91 | 4.75 | 4.81 | 105600 |
| April 9, 2012 | 5.01 | 5.103 | 4.80 | 4.85 | 80642 |
| April 5, 2012 | 4.98 | 5.20 | 4.90 | 5.14 | 243610 |
| April 4, 2012 | 5.08 | 5.13 | 4.97 | 5.00 | 199578 |
| April 3, 2012 | 5.12 | 5.16 | 5.07 | 5.10 | 131865 |
| April 2, 2012 | 5.25 | 5.26 | 5.04 | 5.13 | 112337 |
| March 30, 2012 | 5.35 | 5.45 | 5.23 | 5.28 | 488090 |
| March 29, 2012 | 5.36 | 5.36 | 5.062 | 5.32 | 186640 |
| March 28, 2012 | 5.66 | 5.66 | 5.27 | 5.38 | 59031 |
| March 27, 2012 | 5.70 | 5.74 | 5.59 | 5.66 | 95217 |
| March 26, 2012 | 5.37 | 5.72 | 5.37 | 5.68 | 192361 |
| March 23, 2012 | 5.36 | 5.36 | 5.36 | 5.36 | 0.00 |
| March 22, 2012 | 5.35 | 5.37 | 5.15 | 5.36 | 58989 |
| March 21, 2012 | 5.42 | 5.42 | 5.42 | 5.42 | 0.00 |
| March 20, 2012 | 5.60 | 5.60 | 5.35 | 5.42 | 125976 |
| March 19, 2012 | 5.66 | 5.76 | 5.61 | 5.64 | 52021 |
| March 16, 2012 | 5.82 | 5.82 | 5.650 | 5.68 | 136300 |
FOLD News
Canaccord Genuity Reiterates a 'Buy' on Amicus Therapeutics (FOLD); Encouraged on Upcoming Data
May 11, 9:50AM Street Insider
May 11, 9:50AM Street Insider
Listen to $FOLD Q1 2012 earnings call - live at 05:00 PM, ondemand after - http://stks.co/3mFn
about 19 days ago by earningscast
about 19 days ago by earningscast
Amicus Therapeutics to Announce First Quarter 2012 Financial Results on May 10, 2012
May 04, 10:00AM GlobeNewswire
May 04, 10:00AM GlobeNewswire
$FOLD http://stks.co/3Lqx Long setup. Bullish engulfing. 200MA support.
about 44 days ago by VexTrades
about 44 days ago by VexTrades
$FOLD--Some huge insider buys just came through at 5.70. Do your own research. This looks like a stock offering, but insiders are buying.
about 81 days ago by MicroInsider
about 81 days ago by MicroInsider
Amicus Therapeutics (FOLD) Closes 10M Offering; Nets Proceeds of $62M
Mar 07, 10:16AM Street Insider
Mar 07, 10:16AM Street Insider
Amicus Therapeutics Announces Closing of Underwritten Offering of Common Stock and Exercise of Over-Allotment Option
Mar 07, 10:15AM GlobeNewswire
Mar 07, 10:15AM GlobeNewswire
$FOLD forms bearish "Head and Shoulders Top" chart pattern. http://stks.co/2hZy
about 83 days ago by RecogniaEvents
about 83 days ago by RecogniaEvents
$ECTE i see great potential in this one. A skin glucose monitor with no sticks!! Also long $FOLD for a long term play...
about 87 days ago by Stuckinstock
about 87 days ago by Stuckinstock
From Earlier: Amicus Therapeutics Prices Underwritten Offering of 10M Shares at $5.70
Mar 02, 8:30AM Benzinga
Mar 02, 8:30AM Benzinga
$FOLD Announces Proposed Public Offering of Common Stock; No Amount Given
about 89 days ago by Benzinga
about 89 days ago by Benzinga
Amicus Therapeutics Announces Proposed Public Offering of Common Stock; No Amount Given
Mar 01, 4:01PM Benzinga
Mar 01, 4:01PM Benzinga
Amicus Therapeutics to Present at 2012 RBC Global Healthcare Conference
Feb 28, 11:08AM GlobeNewswire
Feb 28, 11:08AM GlobeNewswire
Canaccord Genuity Reiterates a 'Buy' on Amicus Therapeutics (FOLD); Management Dinner Takeaways
Feb 23, 10:16AM Street Insider
Feb 23, 10:16AM Street Insider
Canaccord Genuity Reiterates a 'Hold' on Amicus Therapeutics (FOLD); Q4/11 Update: Market Focus Shifts to Combo Therapy
Feb 14, 9:06AM Street Insider
Feb 14, 9:06AM Street Insider
Listen to $FOLD Q4 2011 earnings call (EPS -0.25 vs est -0.37) - live at 05:00 PM, ondemand after - http://stks.co/2Nmy
about 106 days ago by earningscast
about 106 days ago by earningscast
Amicus Therapeutics Announces Fourth Quarter and Full-Year 2011 Financial Results
Feb 13, 4:01PM GlobeNewswire
Feb 13, 4:01PM GlobeNewswire
10:50EST $FOLD Up 8% for the day. Reporting Earnings Today. http://stks.co/2NKe #tradeideas #stocks #investing #earnings
about 106 days ago by TradeIdeas1
about 106 days ago by TradeIdeas1
Canaccord Genuity Reiterates a 'Buy' on Amicus Therapeutics (FOLD); WORLD 2012: ERT Combo Proof of Concept
Feb 13, 8:47AM Street Insider
Feb 13, 8:47AM Street Insider
Amicus Therapeutics (FOLD) Reports Patient Screening Profiles From Phase 3 Fabry Study
Feb 13, 7:36AM Street Insider
Feb 13, 7:36AM Street Insider
Amicus Therapeutics Presents Patient Screening Profiles From Phase 3 Fabry Study
Feb 13, 7:31AM Benzinga
Feb 13, 7:31AM Benzinga
$FOLD Presents Preclinical Studies for Gaucher Disease; AVI BioPharma Results From Phase I Clinical Trial. http://stks.co/2LHx
about 109 days ago by abubnic
about 109 days ago by abubnic
$FOLD filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/nqC
about 216 days ago by MarketBrief
about 216 days ago by MarketBrief
$FOLD $6.01 Crowley John F director officer (Executive Chairman) P 20,000 @ $6.04 amnt $120,800 proc'd ($600) 6/17/2011
about 343 days ago by canarionyc
about 343 days ago by canarionyc
$FOLD $7.56 Valenzano Ken officer (VP, Pharmacology & Biology) S 2,250 @ $7.50 amnt $16,875 proc'd ($135) 5/24/2011
about 370 days ago by canarionyc
about 370 days ago by canarionyc
Register for BioNJ's annual meeting held 1/27/11, featured speaker J. Crowley, Amicus $FOLD CEO. Register at http://bit.ly/hxEerO #BioNJADM
about 515 days ago by MDBpartners
about 515 days ago by MDBpartners
Best Stock List recommended $FOLD -Amicus Therapeutics, Inc. on 10/25/2010 16:00:00 and has gained 4.13%! $SPY http://bit.ly/gvoEjM
about 516 days ago by Tieler
about 516 days ago by Tieler
Best Stock List recommended $FOLD -Amicus Therapeutics, Inc. on 10/25/2010 16:00:00 and has gained 4.13%! $SPY http://bit.ly/hLiIKn
about 516 days ago by Tieler
about 516 days ago by Tieler
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| FOLD | 4.91 | -0.08 | -1.60% | 222.80M |
| FOH | 0.37 | +0.00 | +0.00% | 14.40M |
| FOF | 12.20 | +0.11 | +0.91% | |
| FOE | 4.62 | +0.04 | +0.87% | 396.49M |
| FNSR | 15.09 | +0.50 | +3.43% | 1.325B |
| FLY | 12.35 | +0.03 | +0.24% | 316.01M |
| FLXS | 20.04 | +0.05 | +0.25% | 135.13M |
| FLT | 38.37 | -0.09 | -0.23% | 3.181B |
| FLR | 50.44 | +0.73 | +1.48% | 8.422B |
| FLOW | 3.02 | -0.05 | -1.63% | 146.93M |